Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-27

FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for gabapentin submitted by Creekwood Pharmaceuticals LLC. The approval covers changes to an already approved gabape…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)